Remibrutinib beneficial for urticaria after H1-antihistamine treatment
For patients with symptomatic chronic spontaneous urticaria after treatment with second-generation H1-antihistamines, ...
2 Minute Medicine3d
Remibrutinib alleviates symptoms in chronic spontaneous urticaria resistant to H1-antihistamines
In this randomized controlled trial, among patients with chronic spontaneous urticaria who continue to have symptoms while on ...
Daily Jang3d
Remibrutinib proves effective against chronic spontaneous urticaria, study
A new groundbreaking study revealed that Remibrutinib showed promising results in treating chronic spontaneous urticaria.A recent study published in the New England Journal of Medicine outlined the ...
The Pharma Letter6d
Remibrutinib shows strong sleep improvement data in CSU
Novartis (NOVN: VX) has reported new data showing that its investigational BTK inhibitor, remibrutinib, significantly ...
pharmaphorum1d
Novartis cues up filings for remibrutinib in chronic hives
Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long ...
Medscape2d
Key Highlights on Urticaria From AAD 2025: Advances in CSU Treatment and Management
Dr Adam Friedman recounts how AAD 2025 highlighted advancements in chronic spontaneous urticaria management, with discussion on new therapies and the role of diet.
healthday4d
Remibrutinib Beneficial for Urticaria After H1-Antihistamine Treatment
Martin Metz, M.D., from Charité–Universitätsmedizin Berlin, and colleagues examined the efficacy and safety of remibrutinib in patients with symptomatic chronic spontaneous urticaria after treatment ...
pharmaphorum3d
Sanofi trumpets win for oral BTK drug in chronic hives
Cases of liver toxicity in trials have, however, pegged back expectations for tolebrutinib and other drugs in the oral BTK class in late-stage testing for MS, which include remibrutinib ...